SLIT prevents the development of eczema in percutaneous allergen-sensitized mice.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 21900950)

Published in J Invest Dermatol on September 08, 2011

Authors

Béatrice Vanbervliet, Sophie Tourdot, Laurent Mascarell, Paul Rouzaire, Marc Vocanson, Aurore Rozières, Josette Benetière, Philippe Moingeon, Jean-François Nicolas, Ana Hennino

Articles by these authors

Defective planar cell polarity in polycystic kidney disease. Nat Genet (2005) 4.31

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood (2008) 2.50

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood (2004) 2.41

The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell (2004) 2.00

Redefining the progression of lineage segregations during mammalian embryogenesis by clonal analysis. Dev Cell (2009) 1.90

Hair follicle renewal: organization of stem cells in the matrix and the role of stereotyped lineages and behaviors. Development (2005) 1.88

Allergic and irritant contact dermatitis. Eur J Dermatol (2009) 1.71

Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome. Development (2006) 1.54

Allergic contact dermatitis. Eur J Dermatol (2004) 1.52

A retrospective clonal analysis of the myocardium reveals two phases of clonal growth in the developing mouse heart. Development (2003) 1.50

CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology (2006) 1.47

Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol (2005) 1.32

Regulation of dendritic cell recruitment by chemokines. Transplantation (2002) 1.31

Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol (2005) 1.30

Insights into spawning behavior and development of the European amphioxus (Branchiostoma lanceolatum). J Exp Zool B Mol Dev Evol (2007) 1.29

Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol (2012) 1.29

Clonal analysis reveals common lineage relationships between head muscles and second heart field derivatives in the mouse embryo. Development (2010) 1.21

Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol (2002) 1.19

Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood (2003) 1.16

Pathophysiology of urticaria. Clin Rev Allergy Immunol (2006) 1.16

CpG content affects gene silencing in mice: evidence from novel transgenes. Genome Biol (2003) 1.14

Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J Immunol (2009) 1.14

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol (2009) 1.13

Head-tail patterning of the vertebrate embryo: one, two or many unresolved problems? Int J Dev Biol (2006) 1.09

Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest (2012) 1.09

Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. J Allergy Clin Immunol (2010) 1.08

Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol (2008) 1.08

HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. J Immunol (2002) 1.06

Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol (2009) 1.05

Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions. J Immunol (2007) 1.04

CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol (2011) 1.03

Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol (2006) 1.03

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol (2007) 1.00

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol (2008) 1.00

In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects. J Immunol (2005) 0.99

Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells. Immunology (2005) 0.99

Quality control of house dust mite extracts for allergen immunotherapy. Int Arch Allergy Immunol (2013) 0.99

The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol (2004) 0.98

CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol (2006) 0.96

Amphioxus spawning behavior in an artificial seawater facility. J Exp Zool B Mol Dev Evol (2011) 0.95

Characterization of a CD44/CD122int memory CD8 T cell subset generated under sterile inflammatory conditions. J Immunol (2009) 0.95

Redefining the structure of the hair follicle by 3D clonal analysis. Development (2012) 0.94

Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens. Eur J Immunol (2011) 0.94

Hair follicle renewal: authentic morphogenesis that depends on a complex progression of stem cell lineages. Development (2010) 0.93

Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine (2005) 0.92

Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol (2007) 0.92

Clonal separation and regionalisation during formation of the medial and lateral myotomes in the mouse embryo. Development (2002) 0.90

Immediate- and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing. Pharmacoepidemiol Drug Saf (2009) 0.90

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol (2007) 0.90

Laminins, via heparan sulfate proteoglycans, participate in zebrafish myotome morphogenesis by modulating the pattern of Bmp responsiveness. Development (2010) 0.90

Cell coherence during production of the presomitic mesoderm and somitogenesis in the mouse embryo. Development (2002) 0.89

Comparative histology and immunohistochemistry of porcine versus human skin. Eur J Dermatol (2013) 0.89

Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol (2006) 0.89

Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis. Expert Rev Clin Immunol (2005) 0.89

Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol (2012) 0.89

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.89

Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells. J Invest Dermatol (2012) 0.88

Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Eur J Gastroenterol Hepatol (2012) 0.88

Methods in clonal analysis and applications. Reprod Nutr Dev (2005) 0.87

Autoimmune hepatitis in two psoriasis patients treated with inflixmab. J Am Acad Dermatol (2010) 0.87

Adjuvants and vector systems for allergy vaccines. Immunol Allergy Clin North Am (2011) 0.87

Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8+ T cell functions. J Invest Dermatol (2005) 0.87

CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood (2011) 0.86

Progressive restriction of cell fates in relation to neuroepithelial cell mingling in the mouse cerebellum. Dev Biol (2003) 0.86

Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS One (2008) 0.86

Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine. Clin Cancer Res (2002) 0.86

Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol (2011) 0.85

Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells. PLoS One (2012) 0.85

Mucosal immunization application to allergic disease: sublingual immunotherapy. Allergy Asthma Proc (2007) 0.85

Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine (2010) 0.85

Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol (2008) 0.84

Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. Cancer Gene Ther (2003) 0.84

Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell-mediated skin inflammation. J Allergy Clin Immunol (2011) 0.84

Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Vaccine (2007) 0.83

Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy. Clin Mol Allergy (2010) 0.83

Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol (2011) 0.83

Immunological foundations to the quest for new vaccine adjuvants. BioDrugs (2004) 0.83

Induction of allergen-specific tolerance via mucosal routes. Curr Top Microbiol Immunol (2011) 0.82